KLR Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

KLR Investment Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$231K	Sell
2023 Q4	$229K	Buy
2023 Q3	$278K	Sell
2023 Q2	$238K	Sell
2023 Q1	$288K	Sell
2022 Q4	$351K	Buy